Naringin & Neohesperidin Market Trends, Industry & Size 2030

Report Description

Naringin & Neohesperidin Market Outlook

The global Naringin & Neohesperidin market was valued at USD 1,388.9 Mn in 2020 and is projected to reach USD 2,055.1 Mn by 2028, expanding at a CAGR of 5.3% during the forecast period. Blends of juice processed from grapefruit (C. paradisi) and sweet orange (Citrus sinensis) are distinguished from 100% sweet orange juice and from juice blends containing other citrus varieties, which are legally added without a declaration of the mixture.

The distinction is made by determining the levels of flavonoids, naringin, and neohesperidin. Naringin and neohesperidin are flavanone glycosides, a class of flavonoids. Naringin and neohesperidin are only present in certain varieties of citrus. The fruits of the cultivars of sweet orange and tangerine (C. reticulata) do not contain detectable levels of naringin or neohesperidin. Grapefruit, fruit varieties of sour orange (C. aurantium), and 2 tangerine–grapefruit hybrids (K-Early and Sampson) contain naringin.

Get Free Sample Report

Naringin & Neohesperidin Market Report Scope

Naringin & Neohesperidin Market Dynamics

Demand for naringin and neohesperidin is increasing in the food & beverage industry, which is expected to drive the market during the forecast period. In the food & beverage industry, flavonoids are used to improve the quality and stability of products, acting as functional ingredients such as food flavoring and act as health-promoting components.

Naringin is mainly incorporated as a flavoring and a bitter agent. Naringin is used in producing syrups, carbonated drinks, sauces, sweets, confectionery, and bakery products. In some formulations of bitter drinks, and is used to replace quinine.

Naringin is helping in the treatment of metabolic syndrome, obesity, high blood pressure, and diabetes. Naringin represented a wide range of pharmaceutical activities such as anti-cancer and anti-inflammatory activities. It exhibited effects on metabolic syndrome, oxidative stress, genetic injury, bone regeneration, and central nervous system disease.

The neohesperidin drug possesses neuroprotective activity and an anti-proliferative effect on human hepatoma cell lines. Demand for naringin and neohesperidin is increasing in the pharmaceutical industry, which is expected to drive the market during the forecast period.

Naringin and neohesperidin are widely used in making cosmetic products, which is expected to propel the growth of the market during the anticipated period. Cosmetochem International AG has encapsulated citrus-extracted bioflavonoids in liposomes and created Citrolumine 8, a cosmetic active that fades age spots, brightens skin tone, and increases skin luminosity.

Citrolumine 8 contains antioxidant and anti-inflammatory properties owing to its flavonoid content. The high-performance liquid chromatography revealed that Citrolumine 8 contain four citrus flavonoids: hesperidin (3%), naringin (66%), narirutin (15%), and neohesperidin (16%).

Rising awareness regarding several adverse effects associated with the consumption of naringin such as cough, dizziness, headaches, and flushing sensation. Naringin extract can change the metabolism of some drugs, which can cause them to stay in the blood for a longer period of time. This could cause a higher concentration in the blood, which can cause some troublesome effects in the body.

Drugs that interact with naringin supplements such as high blood pressure drugs, cholesterol-lowering drugs, estrogen supplements, sedatives, and calcium channel blockers. Therefore, side effects associated with naringin hinder the market during the forecast period.

Increasing use of the Internet for selling and purchasing products has created new opportunities for small and large manufacturers and suppliers. In the current scenario, more than half of the overall revenue of manufacturers was generated using online sales channels. With the growing use of the internet in developing countries, the online sales of naringin and neohesperidin have gained momentum and are expected to grow at a significant rate during the forecast period.

Naringin & Neohesperidin Market Segment Outlook

By Type

Based on types, the global naringin and neohesperidin market are segmented into naringin and neohesperidin. The naringin segment is further segmented into food grade, pharma grade, and others. The neohesperidin segment is further segmented into food grade, pharma grade, and industrial grade. The naringin segment is expected to grow at a significant pace during the anticipated period, due to the increasing use of naringin in the food industry. It is used in syrups, carbonated drinks, sauces, sweets, and to produce confectionery and bakery products.

Get Free Sample Report

By End-use Industry

Based on end-use industries, the global naringin and neohesperidin market are segmented into food & feed additives, pharma & healthcare, and cosmetics and personal care. Naringin is used as a flavoring agent, which increases the taste of the product by the activation of the taste receptors in the animal feed industry.

Get Free Sample Report

Naringin & Neohesperidin Market Regional Analysis

Based on regions, the global Naringin & Neohesperidin market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is projected to expand at a significant CAGR during the anticipated period, due to increasing awareness about the health-conscious population.

Get Free Sample Report

Key Benefits for Industry Participants & Stakeholders

• In-Depth Analysis of the Naringin & Neohesperidin Market.
• Historical, Current and Projected Market Size in Terms of Value.
• Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
• Industry Drivers, Restraints and Opportunities Covered in the Study
• Recent Industry Trends and Developments
• Competitive Landscape & Strategies of Key Players
• Neutral Perspective on From Naringin & Neohesperidin Market Performance